Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-17-006519
Filing Date
2017-11-13
Accepted
2017-11-13 16:02:52
Documents
72
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q s107913_10q.htm 10-Q 587494
2 EXHIBIT 31.1 s107913_ex31-1.htm EX-31.1 12126
3 EXHIBIT 31.2 s107913_ex31-2.htm EX-31.2 11732
4 EXHIBIT 32.1 s107913_ex32-1.htm EX-32.1 5915
5 EXHIBIT 32.2 s107913_ex32-2.htm EX-32.2 7017
  Complete submission text file 0001615774-17-006519.txt   3498684

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE atos-20170930.xml EX-101.INS 558060
7 XBRL SCHEMA FILE atos-20170930.xsd EX-101.SCH 44970
8 XBRL CALCULATION FILE atos-20170930_cal.xml EX-101.CAL 55713
9 XBRL DEFINITION FILE atos-20170930_def.xml EX-101.DEF 143998
10 XBRL LABEL FILE atos-20170930_lab.xml EX-101.LAB 323217
11 XBRL PRESENTATION FILE atos-20170930_pre.xml EX-101.PRE 256584
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35610 | Film No.: 171195787
SIC: 2834 Pharmaceutical Preparations